Alligator Bioscience Q1 2024: The Next Catalyst Will Be the 18-month Readout - Redeye

Redeye comments on Alligator Bioscience's Q1 report, including the sub-optimal funding situation after the rights issue and upcoming catalysts, in particular the 18-month OPTIMIZE-1 readout.

Länk till analysen i sin helhet: https://www.redeye.se/research/1002837/alligator-bioscience-q1-2024-the-next-catalyst-will-be-the-18-month-readout?utm_source=finwire&utm_medium=RSS